Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Clinical Pediatric Hematology-Oncology ; : 21-36, 2017.
Article Dans Coréen | WPRIM | ID: wpr-197959

Résumé

Pediatric renal tumors represent a diverse group, which include Wilms' tumor (WT), renal cell carcinoma (RCC), clear cell sarcoma of the kidney (CCSK), congenital mesoblastic nephroma, malignant rhabdoid tumor of the kidney (MRTK) and primitive neuroectodermal tumor. WT (85%) and RCC (8%) are the most prevalent types. WT predominates among the 1- to 10-year age group, but RCC exceeds WT in children over age 10 years. Pediatric renal tumors are genetically, histologically and clinically heterogeneous. The overall survival for children with localized WT is currently more than 90%, whereas poorer survival rates are observed for anaplastic WT, metastatic WT, metastatic CCSK, MRTK, metastatic RCC and relapsed WT. Therefore risk-stratified treatment is important to minimize treatment morbidity while preserving survival. This review focuses on distinct characteristics of each tumor type and optimal stratified treatment.


Sujets)
Enfant , Humains , Néphrocarcinome , Rein , Néphrome mésoblastique , Tumeurs neuroectodermiques primitives , Tumeur rhabdoïde , Sarcome à cellules claires , Taux de survie , Tumeur de Wilms
2.
Clinical Pediatric Hematology-Oncology ; : 21-36, 2017.
Article Dans Coréen | WPRIM | ID: wpr-788599

Résumé

Pediatric renal tumors represent a diverse group, which include Wilms' tumor (WT), renal cell carcinoma (RCC), clear cell sarcoma of the kidney (CCSK), congenital mesoblastic nephroma, malignant rhabdoid tumor of the kidney (MRTK) and primitive neuroectodermal tumor. WT (85%) and RCC (8%) are the most prevalent types. WT predominates among the 1- to 10-year age group, but RCC exceeds WT in children over age 10 years. Pediatric renal tumors are genetically, histologically and clinically heterogeneous. The overall survival for children with localized WT is currently more than 90%, whereas poorer survival rates are observed for anaplastic WT, metastatic WT, metastatic CCSK, MRTK, metastatic RCC and relapsed WT. Therefore risk-stratified treatment is important to minimize treatment morbidity while preserving survival. This review focuses on distinct characteristics of each tumor type and optimal stratified treatment.


Sujets)
Enfant , Humains , Néphrocarcinome , Rein , Néphrome mésoblastique , Tumeurs neuroectodermiques primitives , Tumeur rhabdoïde , Sarcome à cellules claires , Taux de survie , Tumeur de Wilms
SÉLECTION CITATIONS
Détails de la recherche